Amsel Medical Corporation
Cambridge, MA
- UEI
- UUM9WLJWJQ24
- CAGE
- 6PXF8
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 705 Cambridge St, Cambridge, MA 02141, USA
- Website
- amselmedical.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $2,010,841 |
| FY2024 | $3,500,000 |
Contract awards
Similar vendors
About the company
Amsel Medical Corporation is a for-profit medical technology manufacturer located in Cambridge, Massachusetts, specializing in innovative medical device research and development. Registered in the System for Award Management (SAM) since 2012, the company focuses on developing advanced medical technologies with a particular emphasis on hemorrhage control and emergency medical interventions. The corporation has established itself as a key innovator in medical technologies, particularly for military and defense applications, working closely with federal agencies to advance critical medical solutions.
The company has secured multiple federal contract awards, primarily from the Air Force Research Laboratory, centered on developing cutting-edge medical technologies for hemorrhage control. Amsel Medical Corporation has been awarded several Small Business Innovation Research (SBIR) Program contracts, with a total value exceeding $9 million, specifically focused on developing rapid site-specific needle delivery adjustable vessel occlusion devices for controlling junctional and non-compressible hemorrhage. These contracts, ranging from Phase II to Phase III actions, have been predominantly total small business set-aside procurements, demonstrating the company's commitment to innovative medical device research. The contracts span from 2020 to 2027, with the most recent award being a $7,453,975 Cost Plus Fixed Fee definitive contract from the U.S. Air Force, scheduled for completion by March 30, 2027. Additionally, the company has performed on-site training and support services for the Medical Command, further illustrating its versatility in providing medical technology solutions to federal agencies.
Quick answers
Is Amsel Medical Corporation registered in SAM.gov?
Yes. Amsel Medical Corporation's SAM.gov registration is active through September 30, 2027.
How much has Amsel Medical Corporation received in federal contracts?
Federal contracts obligated $2,010,841 to Amsel Medical Corporation in fiscal year 2025 and $5,510,841 in fiscal years 2023 through 2027.
What is Amsel Medical Corporation's most recent federal award?
Amsel Medical Corporation's most recent federal contract award is Non-surgical control of junctional and non-compressible hemorrhage via percutaneously delivered adjustable vessel… (FA238424CB015), from Air Force, on September 30, 2024.
On GovTribe
See Amsel Medical Corporation's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors